Michael (Mike) Greeley

Senior Managing Director

$705M

Volume

$253M

Sold

$452M

Financed

14

Closed

3M

Area

Focus

MASSACHUSETTS

SALE

Office

On the web

About

Michael Greeley is a senior managing director of Newmark’s Medical-Academic Practice Group in Boston, overseeing capital markets for the team, which he joined in 2008. With a specialty in medical office building (MOB) investment sales, Michael and his team, led by Rob Griffin, have been involved in the great majority of institutional trades in the Greater Boston market. Michael has overseen... Read More

Top Deals

Anchor Health Properties & Australian Retirement Trust Acquire Medical Office Portfolio In Seattle And Charlotte For $62M

SOLD

Share this deal

Open in a new tab

Anchor Health Properties & Australian Retirement Trust Acquire Medical Office Portfolio In Seattle And Charlotte For $62M

NationalMedical Office

+ 6

110 days ago

SOLD

Share this deal

Open in a new tab

Remedy Medical Properties Acquires Office Building In Andover, MA For $55.2M

MassachusettsOfficePPSF: $788

+ 4

2 years ago

SOLD

Share this deal

Open in a new tab

Lincoln Property Company & Stars Real Estate Investments Acquire Office Building In Wellesley For $36.55M

MassachusettsOfficePPSF: $281

2 years ago

SOLD

Share this deal

Open in a new tab

Celera Properties & AEW Acquire Medical Office In Methuen, MA For $29.5M

MassachusettsOfficePPSF: $312

+ 5

2 years ago

SOLD

Share this deal

Open in a new tab

Principal Real Estate Investors Acquires Medical Office In Natick, MA For $24.9M

Massachusetts

2 years ago

Stats

FAQs

How many deals has Michael (Mike) Greeley closed?

Michael (Mike) Greeley has closed 11 sales, 3 loans.

When was the last time Michael (Mike) Greeley closed a deal?

Michael (Mike) Greeley's most recent deal was on January 08, 2024.

What are Michael (Mike) Greeley’s biggest deals?

Michael (Mike) Greeley's largest deals include a sale of $62,000,000.00 for Seattle, Washington, and a loan of $200,000,000.00 for Texas, United States.